-
Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery
firstwordpharma
January 13, 2019
Charles River Laboratories International, Inc. (NYSE: CRL) and Atomwise, Inc. today announced the formation of a strategic alliance that offers clients access to Atomwise's artificial intelligence (AI)-powered, structure-based, drug design technology, whi
-
Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery
firstwordpharma
January 13, 2019
Charles River Laboratories International, Inc. (NYSE: CRL) and Atomwise, Inc. today announced the formation of a strategic alliance that offers clients access to Atomwise's artificial intelligence (AI)-powered, structure-based, drug design technology, whi
-
Charles River and Distributed Bio Enter Exclusive Partnership
pharmafocusasia
November 28, 2018
Charles River Laboratories International, Inc today announced that it has entered into an exclusive partnership with Distributed Bio, Inc., a leader in the computational design and optimization of antibody discovery platforms.....
-
Fox Foundation and Charles River renew Parkinson’s research collaboration
fiercebiotech
May 07, 2018
Charles River Laboratories and The Michael J. Fox Foundation for Parkinson’s Research have extended their collaboration, including grants to support work in protein phenotyping and the evaluation of small molecule inhibitors.
-
Charles River doubles down on CNS research with Brains On-Line buy
fiercebiotech
August 10, 2017
Charles River acquires Brains On-Line for €18 million, enhancing its position as a single-source provider for a broad portfolio of CNS discovery services.